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@/mm2. In comparison, in the PTS reduead current density waa observed
in infarcted areaa showing hype-or akineaia in LV angiography.
Thua, combination of MRI and multichannel MCG permits time dependent
3dimensional reconstruction ofcurrentdensify onthe LVsurface. Thecurrent
densily racon@uctions were highly uniform inthe20VOLevaluated. In MCG,
myocardial infarctlonawere representad as areas of reduced maximal current
density.
H1002100 What ia The Impact of Chronic Low Coronary
Flow Gradea on Myocardial Viability?
A. A1-Mohammad,MY. Norton 1, S. Walton. Cardiac Deper?ment,Abardaen
Royal Infirmary Aberdeen, Scotland, 1Deperfment of Madical Physics,
Aberdeen University Aberdaen, Scotland
The low Thrombolysis In Myocardial Infarction (TIMI) coronary flow grades
(TIMI Oor 1), represent failure of reperfusion. However, the impact of suba-
cute or chronic TIMI Oor 1 flow grades on the myoeardium is not defined. We
studied the relationship between TIMI Oor 1 flow grades in a coronary artery,
and the viability of the myoeardial region subtended by that artery. Positron
emission tomography (PET) criteria was used to determine the viability of
the ischemic dysfunctional ragions. The myceardium is hibernating when
there is significant metabolic-perfusion mismatch, and non-viable when a
matched defect is presant. N-13-ammonia is the perfusion marker,and F-18-
fluorodeoxyglucoae is the metabolic marker. The images are displayed on
polar mapa. Each map is divided into 5 ragions. Thirly patients with severe
left ventricular dysfunction were studied. Thirly-one dysfunctional regions
were subtended by vessels with TIMI Oor 1 flow grades. Hibernation was
found in six ragiona (group A). The remaining 25 regions were not viable
(group B). We reviewad the angiograma of the patients in the two groups.
All regions in (group A) were supported by significant collaterals leading to
ratqrade filling of the artery with impaired forward flow. None of group B
ragions were supportad by collaterals. Cone/usion:Chronic or subacute TIMI
O or 1 flow grades are not associated with viable myocardium, unless the
region is supported by collateral circulation.
m1002101 Dynamic Poaitron Emiaaion Tomography Uaing
14 (R,S)-[F-18] Fluoro-8-Thiaheptsdecanolc Acid
Detecta Preserved Myocardial Viability in
Regiona with Reduced Perfuaion
J. vom Dahl, G. Schulz, L. Banneitz, H.J. Kaiser, U. Cremerius, K.-C. Koch,
U. Buell, P.Hanrath. Urriversityof Aachen Hospital, Aacfren, Germany
Previous studies indicated that static PET imaging using 14 (R,S)-[F-18]
Fluoro-6-ThiaheptadecSnOicAcid (~HA) doas not discriminate between
preserved and abaent myocerdial viability in dyefunctioning regions with
reduced perfuaion.
To investigate the diagnostic value of FTHA in combination with dynamic
PET imaging for viabiiity assessment, 21 patients with advanced coronary
heart diseaee(all with previous myocardial infarctionandmultivessel disease,
EF 34 + 11%) underwent dynamic PET (acquisition for 80 (12 x 5) minutes)
after injection of 7 mCi FTHA. For individual comparison, myocardial viability
waa assessed by perfuaion imaging using SPECT with 10 mCi Tc-99 m
saetamibi and PET imaging with 5-7 mCi F-18 fluoro-daoxyglucose (FDG).
Quantitative tracer uptake analysis was performed for all three image sets
with normalization to the region with maximal Perfusion and was exPressed
es ‘A of thia reference ragion. The FTHA uptake rate conatant (Ki) was
derived by Patlak’s approach. 190 regions with markedly reduced parfusion
(sestamibi c 60%) were categorized by the FDG uptake: mismatch (FDG ?
70%), mild match (FDG 50-69%), and scar (FDG < 50%):
group(n) aestsmibi(“A) FDG (%) FII-IA (“/6) F17-IAKi (Pmo~min)
mismatch(52) 40& 8 87& 13”” 44& 21 0045 * 0.031””
mildmstch(53) 38*9 5e* 6* ‘lai 14 0.037 * 0.021
scar (e5) 34*9 32& 10 32& 12 0.031 * 0.015
*p< 0.05 vs sear; **p< 0.01 vs scar
In ragiona with reduced perfusion, static FTHA uptake did not discrim-
inate between mismatch regions and ecar due to the flow dependency of
&oxidation. Metabolic imaging by dynamic PET with FTHA demonstrated
a significant difference of FTHA kinetics between myocardial regions with
prasewad viability and those with sear reflaeting the maintained metabolic
activity in miamatch regions.
/1002-1021 pETEvaktatiOnof MyocardialNorepinephrhte
Uptake in Idiopathic Dilated Cardiomyopathy
C.Cau=in, B. Mazoyer,C. Loc’h, J.-L. Dubois Rand6, F. Pouillan,
A. Castaigne, P.Merlet. Cardiology University Hospita/, Cr6tei/, SHFJ,
DRM, Omay France
Data concerning myocardial norepinephrine (NE) reuptake (U) in patients
with idiopathic diiatad cardiomyopathy (lDC) are controversial and no infor-
mation is available on the regional U variation. PET with 76Br-Metabromo-
benzylguanidine (MBBG) as a tracer, an unmetabolizable analogue of NE
permits the global and regional quantification of U. In heart transplant pa-
tients, we have previously shown that the nonspecific uptake of MBBG was
very low. Using this method, we have evaluated the U in 21 patients (pts)
with congestive heari failure due to IDC in comparison with 6 normal subjects
(C). Pts were in NYHA class II to IV, had a mean radionuclide LVEF of 25
+ 11%and nostenotic lesion on coronary angiogram. Myocardial blood flow
(MBF) was asaessad uaing HZ150bolus technique. Pts and C were injected
with 37 to 61 MBq of MBBG and data were acquired for 60 min. Time-activity
curve generatad in left ventricle myocardium regions of intereat were fittad
to a 2-compartment model including 3 parameters: A spillover fraction and 2
rates constant that refer to fonvard (kl) and reverse (k2) transpcmtsof MBBG
across the capillary and tissue membranes. The U was evaluated using the
fixation coefficient (FC) defined as the kl on MBF ratio. Resu/fs:
kl (ml-i inn-i) k2 (inn-i) MBF(ml-i inn-l) FC(%)
c 0.52+ 0.09 0.11* 0.01 0.66+ 0.11 0.61+ 0.16
Fts 0.41+ 0.1” 0,12+0.04 0.65+ 0.17 0.63+ 0.14
(*p < 0.05)
Regional analysis revealed heterogeneity of FC: +33% in the septum and
–19% in the apex (p -=0.001). Thus, impaired NE reuptake in IDC appears
to be a regional rether than a global process.
m1002103 Developmental Changea in Myocardial Glucoae
Metabolism in Non-Human Primatea Uaing
Poaitron Emission Tomography
V. Allada, M.J. Raleigh, B. Jacobs, D.B. Pollack, G.M. Satou, M.E. Pheipa,
H.R. Schelbert. UCLA School ofkfedickre, Los Angeles, CA, USA
Myocardial substrate metabolism in lower neonatal animals is character-
ized by high glumse utilization rates (MRGIc) followed by a decline with
age. To determine whether (A) simiiar age-related changes in myocardiai
MRGIc occur in primates, (B) aubetrate availability accounts for age-related
differences, and (C) subetrate aeiection responds to changea in circuiting
metabolizes, MRGIc was measured non-invaeively with ‘sF-deoxyglucose
(FDG) and PET in 24 Vewet monkeys, ages 7 day to 11 year, in the fasted
(n = 15) or glucoee-loadad state (n = 9). Input function was derived from
serial arterial blood samples (for blood pod tracer activity and substrate lev-
els). PET4erivad myocardial FDG concentrations were corrected for partial
voiume effect baaad on m-Mode echo wall thickness. In the fasting state,
MRGIc was 7-fold higher in infants, aga <8 mo (1.1 + 0.3 &mol/min/g)
than in adults, age > 10 mo (0.2 & 0.1) (p < 0.001). With glueoae-load,
MRGIc in infants (2.6 + 9 wmollminfg) was 4-fold greater (p = 0.05) than in
adults (0.6 & 0.2). In response to a substrate challenge: (A) adult monkeys
had a4-fold increase in MRGIc (glucose-loaded/fast), similar to adult human
vaiues; and (B) while infants had higher MRGlc’e, only a 2-foid MRGIc in-
crease was noted. Age-related glucose-loaded MRGIc differences could not
be acmuntad for by differences in plasma rnetabolites (glucose, insulin, free
fatty acids or lactate). When MRGIc was plotted as a function of age, the
transition to the adult myocardial glucose utilization occurred by 10 months
of age. Conclusions: In non-human primates, MRGIc declines as a function
of age in both the fasting and glucose-loaded states, which agree with the
findings in lower animals. PET-derfved MRGIc in adult primates are simi-
lar to PET-derived adult human values. Finally, neonatal monkeys have an
attenuated MRGIc response to glucose load as compared to adults.
11OO2-104I AaeassmentofGkOse”t iiizatiOnin the
Isolated Rat Heart Using 1,3,4,
8-tetra-acetyl-2-[F-18]-2-deoxy-D-glucoee
(acetyl-FDG) and Inaulin
N. Nguyen, M, Herz, S. Egert, S. Ziegler, G. Stbcklin, M. Schwaiger.
TechniacheUniversit# Mtinchen, Germany
Previous studies have reported that insulin stimulates glumse transporter
translocation and increases fluorodeoxyglucose (FDG) uptake in the heart.
It has also been suggested that the glucose transponderdependent cellular
uptake of FDG is rate-limiting in exogenous glucoee utilization. Thus, the
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purpose of this study is to evaluate glucose utilization in the isolated rat heart
at baseline and with insulin stimulation using acafyl-FDG, which is taken
up independently of trensport. It is hydrolyzedand phosphorylatad within
the cells similarly to FDG. Heatts from fasted, male Sprague-Dawley rats
were excised and perfused according to Langendorff with Krebs-Hensleit
bicarbonate buffer containing Acetyl-FDG and 10 mM glucose at constant
pressure of 60 mmHg. After baseline measurements, hearts were perfused
with insulin (100 nM) addad to perfusate. Radioactivity was monitored using
BGO detector interfaced with a computer. Time-activity curves were decay
correctadand normalized toradioactivifyin perfuaate.Slopaswerecalculated
fmm fitted Iinearcuwesas an index of rate of tracer accumulation (ml/g/min).
Baseline accumulation of acatyl-FDG (0.155 + 0.009) was approximately
7 times faster than that of FDG (0.024 + 0.005) in the same model. After
addition of insulin, there wee a clearance ofacetyl-FDG (–0.029 + 0.001) in
contrast to results with FDG, which showed an approximately 6-fold increase
in uptake compared to baseline (0.113 + 0.057). Approximately 10 minutes
after perfusion with insulin, however, acetyl-FDG was taken up again at a
reduced rate (0.023 + 0.006, 15% of baseline).
Thus, the faster accumulation of acefyl-FDG compared to FDG provide
further evidence that transpotl is rate-limiting for glucose utili=tion at baee-
Iine in the isolated rat heart. The initial clearance of acetyl-FDG after insulin
suggest that the increase in glucose transpml stimulated by insulin increased
cellular glucose concentration, which competes with acatyl-FDG for hexok-
inase activity, causes a net back-diffusion of the tracer. After approximately
10 minutes, glucose transport again appears to be rata-limiting; hence, the
positive myocardial accumulation of acatyl-FDG. The presentad dual tracer
technique may provide new insights into the roles of transpoti and phospho-
rylation in the regulation of exogenous glucose utilization.
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m1003110 CanLsrftVentricularDiameterebe Used toAesese Left Ventricular Remodeling?
K.S. Dujardin, M. Enriquez-Sarano, A. Rossi, J.B. Seward. Mayo Clinic,
Rocheste4 MN, USA
Left ventricular diameters (LV) are easy to measure and commonly used
as substitutes for volumetric analysis to evaluate LV remodeling caused by
LV overload or dysfunction. However, their impact on outcome is disputed,
suggesting that they may notadequately aasess LVremodeling.Todetermine
thevalidityof LVdiameters intheassessment of LVremodeling, LVdiameters
by M-mode and volumes by biplane Simpson’s rule were prospectively and
simultaneously measured in 463 patienta (289 men, age 62 + 15); 46 normal
subjects, 53 with aortic regurgitation, 2S1with mitral regurgitationand83 with
LV dysfunction. The LVejection fraction (EF) and wall stress were calculated
using the M-mode and 2D volumes. The correlation between diameters and
volumes was good both at end-systole (r = 0.91, p < 0.001) and at end-
diastole (r= 0.66, p < 0.001). However, the relation was exponential with
increasing 95% C.1(sss figures). The calculated EF and wall stress using LV
diameters and using LV volumee correlated linearly with a limited range of
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error (respectively, r = 0.95, SEE= 5%, p <0.001 and r = 0.95, SEE= 10%,
p < 0.001).
Weconcludethatfor the assessment of LV remodeling M-mode diameters
1) allow acceptable estimation of EF and wall etress and 2) correlate signifi-
cantly to the LVvolumes, but 3) are hinderad by a wide range of error for the
assessment of LVsize, especially for enlarged ventricles, suggesting that LV
volume measurement should be the preferred method of echocardiographic
assessment of LV remodeling.
-~ The Dependenceofthe EwaveonPuhnonary
Venoue Flow: Mathematical Solution with In Vivo
Verification
R.Y.Grimes, R.A. Levine, A.P. Yoganathan, S.D. Nikohc. Massachusetts
General Hospitel, Boston, MA, USA, Stanford University Medical School,
Stanford, CA, USA
The E wave has become parl of our aaaeesment of LV diastolic function.
However, it is load-dependent and varies with left atrial pressure (LAP). This
pressure is supported by pulmona~ venous (PV) inflow and its momentum at
mitral valve opening (MVO), which may vary indepandentof intrinsic LV dias-
tolic properties and initial diastolic LAP; for example, PV momentum at MVO
is near zero in atrfal fibrillation. We studied this effect in two ways: (1) Math-
ematiceily, by mmbining an elaatance model for pressure with the unsteady
Bernoulli equation into a system of differential equationa to derive an analyt-
ical solution for the E wave related to PV, LA, and LV.diastolic mmplianca
and relaxation time; IA pressure and PV velocity at MVO; as well as PV and
mitral inertance and area. (2) In 9 open-cheat dogs under right-heart bypass
to measure the E wave in the beat before and after computer controlled PV
occlusion at MVO. Results: The mathematical simulation showad that with
all other factors being equal, including initial LAP, as the initial PV velocity
decreased from 40 crris to zero, the E wave peak velocity and deceleration
time decreased to 70% of their initial values. Under comparable conditions
in vivo, the same magnitude of change was obsewed (peak E = 70.4 + 15.8
VS. 50.8 + 12.1 CNdS, II < 0.05).
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Conclusions: The initial PV”flow momentum is an important additional
determinant of the E-wave because it suppofls atrial pressure. This momen-
tum may vary independent of intrinsic LV diastolic properties and initial LAP.
Therefore the initial velocity of PWflow should be considered in physiologic
assessments of diastolic function based on the E wave.
I 1003-1121 DecreaseOfMitraiRegurgitationWithHeart
FailureTreetmentis Dueto a Reductioninthe
RegurgitantOrifice
L.B. Rosario, R.T.Lee, S.D. Solomon, L.W. Stevenson, S.C. Reimold.
Brigham and Women’s Hospital, Boston, MA, USA
Although treatment of congestive heart failure is associated with a dacraaaa
in the severity of mitral regurgitation, the mechanisms for this reduction
are incompletely understood. To explore mechanisms for this decrease, we
performed echocardiography before and after therapy to decrease filling
pressures in 12 patients with heart failure. In addition to hemcdynamic vari-
ables, echocardiographic variables were measured blindly. Mitral regurgitant
flow was determined from color m-mode proximal isovelocity surface areaa
and the effective regurgitant orifice area was calculated as: Regurgitant flow
integraVragurgitant velocity integrai. Results: Tailored therapy resulted in a
decrease in systolic blood pressure (104+ 10 mmHg to 92 + 11 mmHg, p =
0.005) and pulmonary wedge pressure (30 + 7 mmHg to 21 + 5 mmHg, p <
0.001). Cardiac index increased from 1.90 + 0.47 to 2.36 + 0.44 Umirdrr?,
(P= 0.03). Mitralregurgitantflowdecreased from 44.4 + 32.6 ml to 11.6+
9.6 ml (p = 0.003). Although the effective regurgitant orifice area decreased
with therapy (0.36 +0.33 cmz to 0.11 * 0.01 cm2, p =0.01), this wee not due
to any change inthe peak Doppler-derivedventriculo-atrialsystolicpressure
gradient(64.4 + 17.8 to 63.1 + 14.4 mmHg,p = NS). Conclusion: Heart fail-
